세계의 백신 보관 및 포장 시장 : 시장 규모, 점유율, 동향 분석 - 기능별, 지역별, 부문별 예측(2025-2030년)

Vaccine Storage And Packaging Market Size, Share, & Trends Analysis Report By Function (Storage, Packaging), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,590,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,034,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,922,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

백신 보관 및 포장 시장의 성장 및 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 백신 보관 및 포장 시장 규모는 2030년까지 470억 2,000만 달러에 달할 것으로 예측되며, 2025-2030년 11.1%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예측되고 있습니다.

제조업체의 효율적인 보관 및 포장 서비스에 대한 수요의 대폭적인 성장과 예방 접종률의 향상에 중점을 둔 정부 기관이 시장을 견인하고 있습니다.

각 지역에서 활동하는 여러 정부기관과 국제보건기관은 백신의 입수 가능성을 확보하고 접근을 개선하며 효과적인 배포를 함으로써 예방 접종률을 높이는 데 주력하고 있습니다. 이에 따라 각 지역에서 백신 보관 및 포장 서비스 수요가 크게 증가하고 있습니다. 세련된 의료 인프라가 부족하기 때문에 우수한 패키징에 대한 요구가 높아지고 있습니다.

주요 시장 진출 기업에 의한 기술 혁신 및 전략적 진보, 그리고 시장 포지션을 강화하기 위해 보관 능력 향상에 주력하는 기업이 늘어나고 있는 것이 유리한 성장 기회를 창출하고 있습니다. WHO와 Gavi 등의 조직이 시작한 예방 접종 프로그램은 시장 수요 확대에 기여하고 있습니다.

백신 보관 및 포장 시장 보고서 하이라이트

• 복수의 정부에 의해 개시된 예방 접종 프로그램에 관련한 효율적인 보관에 대한 수요 증가로 보관 부문이 백신 보관 및 포장 시장의 55% 이상의 매출 점유율을 차지했습니다.
• 보관 서비스는 냉장고, 냉동고, 액세서리 등의 보관 기기보다 큰 시장 점유율을 차지했습니다.
• 포장 재료로는 백신 백, 바이알, 앰풀이 최대 시장 점유율을 차지했습니다.
• 북미는 복수의 백신 제조업체의 존재, 견조한 창고업, 예방접종 프로그램에 대한 국제 보건 기관의 관여에 의한 수요 증가로 2024년의 세계 산업을 지배했습니다.
• 2025년 4월, DHL은 생명과학 및 의료 분야에서 물류 능력을 강화하기 위해, 약 22억 6,000만 달러를 투자한다고 발표했습니다.

목차

제1장 분석 방법 및 범위

제2장 주요 요약

제3장 백신 보관 및 포장 시장 : 변동 요인, 경향 및 범위

• 시장 연관 전망
  • 상위 시장 전망
  • 관련 및 부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 백신 보관 및 포장 시장 : 분석 툴
  • 업계 분석 : Porter's Five Forces 분석
  • PESTEL 분석

제4장 백신 보관 및 포장 시장 : 기능별 추정 및 동향 분석

• 기능별 대시보드
• 백신 보관 및 포장 시장 : 기능별 변동 분석
• 세계의 백신 보관 및 포장 시장 : 기능별 시장 규모와 동향 분석(2018-2030년)
• 보관
  • 보관 설비
  • 서비스
• 포장
  • 재료
  • 유형

제5장 백신 보관 및 포장 시장 : 지역별 추정 및 동향 분석

• 시장 대시보드 : 지역별
• 시장 점유율 분석 : 지역별(2024년, 2030년)
• 백신 보관 및 포장 시장 : 지역별 주요 포인트
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 태국
  • 호주
• 라틴아메리카
  • 브라질
  • 아르헨티나
  • 콜롬비아
  • 칠레
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 쿠웨이트

제6장 경쟁 구도

• 최근 동향 및 영향 분석 : 주요 시장 진출 기업별
• 기업 및 경쟁의 분류
• 벤더 상황
  • 주요 기업의 히트맵 분석(2024년)
• 기업 프로파일
  • Lineage, Inc.
  • AmerisourceBergen Corporation
  • DHL
  • DB SCHENKER
  • CARDINAL LOGISTICS
  • MCKESSON CORPORATION
  • Thermo Fisher Scientific Inc.
  • PHCbi(PANASONIC HEALTHCARE CO., LTD)
  • American Biotech Supply
  • Arctiko
  • NIPRO

AJY

영문 목차

영문목차

Vaccine Storage And Packaging Market Growth & Trends:

The global vaccine storage and packaging market size is anticipated to reach USD 47.02 billion by 2030 and is anticipated to expand at a CAGR of 11.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Significant growth in demand for efficient storage and packaging services by manufacturers and the focus of government agencies on improving immunization coverage drive the market.

Multiple government agencies and international health organizations working across regions have focused on enhancing immunization coverage by ensuring vaccine availability, improved access, and effective distribution. This has significantly increased the demand for vaccine storage and packaging services across regions. The lack of sophisticated healthcare infrastructure has increased the requirements for packaging excellence.

Innovations, strategic advancements by key market participants, and the increasing focus of multiple companies on improving storage capacity to strengthen their market positions are creating lucrative growth opportunities. Immunization programs initiated by organizations such as the WHO and Gavi contribute to the growing market demand.

Vaccine Storage And Packaging Market Report Highlights:

• The storage segment dominated the vaccine storage and packaging market with more than 55 % revenue share, owing to the growing demand for efficient storage linked to immunization programs initiated by multiple governments.
• Storage services held a larger market share than storage equipment such as refrigerators, freezers, and accessories.
• Vaccine bags, vials, and ampoules accounted for the largest market share in packaging materials.
• North America dominated the global industry in 2024, owing to the presence of multiple vaccine manufacturers, a robust warehousing industry, and increasing demand driven by the involvement of international health organizations in immunization programs.
• In April 2025, DHL announced an investment of nearly USD 2.26 billion to enhance its logistics capacities in the life sciences and healthcare sectors.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Function
  • 1.2.2. Regional Scope
  • 1.2.3. Estimates and Forecasts Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type Outlook
  • 2.2.2. Management Outlook
  • 2.2.3. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Vaccine Storage and Packaging Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Vaccine Storage and Packaging Market Analysis tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrant
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis

Chapter 4. Vaccine Storage and Packaging Market: Function Estimates & Trend Analysis

• 4.1. Function Segment Dashboard
• 4.2. Vaccine Storage and Packaging Market: Function Movement Analysis
• 4.3. Global Vaccine Storage and Packaging Market Size & Trend Analysis, by Function, 2018 to 2030 (USD Million)
• 4.4. Storage
  • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Storage equipment
    • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2.2. Refrigerator
      • 4.4.2.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2.3. Freezer
      • 4.4.2.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2.4. Others (accessories)
      • 4.4.2.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Service
    • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3.2. Warehouse storage
      • 4.4.3.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3.3. Transportation (Cold Retainers)
      • 4.4.3.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.5. Packaging
  • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Material
    • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2.2. Vaccine bags, vials, ampoules
      • 4.5.2.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2.3. Corrugated boxes
      • 4.5.2.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2.4. Others
      • 4.5.2.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Type
    • 4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3.2. Primary
      • 4.5.3.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3.3. Secondary
      • 4.5.3.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3.4. Tertiary
      • 4.5.3.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Vaccine Storage and Packaging Market: Regional Estimates & Trend Analysis

• 5.1. Regional Market Dashboard
• 5.2. Regional Market Share Analysis, 2024 & 2030
• 5.3. Continuous Bioprocessing Market By Region: Key Takeaways
• 5.4. North America
  • 5.4.1. U.S.
    • 5.4.1.1. Key Country Dynamics
    • 5.4.1.2. Regulatory Framework/ Reimbursement Structure
    • 5.4.1.3. Competitive Scenario
    • 5.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Canada
    • 5.4.2.1. Key Country Dynamics
    • 5.4.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.4.2.3. Competitive Scenario
    • 5.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Mexico
    • 5.4.3.1. Key Country Dynamics
    • 5.4.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.4.3.3. Competitive Scenario
    • 5.4.3.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.5. Europe
  • 5.5.1. UK
    • 5.5.1.1. Key Country Dynamics
    • 5.5.1.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.1.3. Competitive Scenario
    • 5.5.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.2. Germany
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.2.3. Competitive Scenario
    • 5.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.3. France
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.3.3. Competitive Scenario
    • 5.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.4. Italy
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.4.3. Competitive Scenario
    • 5.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.5. Spain
    • 5.5.5.1. Key Country Dynamics
    • 5.5.5.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.5.3. Competitive Scenario
    • 5.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.6. Denmark
    • 5.5.6.1. Key Country Dynamics
    • 5.5.6.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.6.3. Competitive Scenario
    • 5.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.7. Sweden
    • 5.5.7.1. Key Country Dynamics
    • 5.5.7.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.7.3. Competitive Scenario
    • 5.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.8. Norway
    • 5.5.8.1. Key Country Dynamics
    • 5.5.8.2. Regulatory Framework/ Reimbursement Structure
    • 5.5.8.3. Competitive Scenario
    • 5.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.6. Asia Pacific
  • 5.6.1. Japan
    • 5.6.1.1. Key Country Dynamics
    • 5.6.1.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.1.3. Competitive Scenario
    • 5.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.2. China
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.2.3. Competitive Scenario
    • 5.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.3. India
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.3.3. Competitive Scenario
    • 5.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.4. South Korea
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.4.3. Competitive Scenario
    • 5.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.5. Thailand
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.5.3. Competitive Scenario
    • 5.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.6. Australia
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Regulatory Framework/ Reimbursement Structure
    • 5.6.6.3. Competitive Scenario
    • 5.6.6.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.7. Latin America
  • 5.7.1. Brazil
    • 5.7.1.1. Key Country Dynamics
    • 5.7.1.2. Regulatory Framework/ Reimbursement Structure
    • 5.7.1.3. Competitive Scenario
    • 5.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7.2. Argentina
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.7.2.3. Competitive Scenario
    • 5.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7.3. Columbia
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.7.3.3. Competitive Scenario
    • 5.7.3.4. Columbia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7.4. Chile
    • 5.7.4.1. Key Country Dynamics
    • 5.7.4.2. Regulatory Framework/ Reimbursement Structure
    • 5.7.4.3. Competitive Scenario
    • 5.7.4.4. Chile Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.8. MEA
  • 5.8.1. South Africa
    • 5.8.1.1. Key Country Dynamics
    • 5.8.1.2. Regulatory Framework/ Reimbursement Structure
    • 5.8.1.3. Competitive Scenario
    • 5.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8.2. Saudi Arabia
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Regulatory Framework/ Reimbursement Structure
    • 5.8.2.3. Competitive Scenario
    • 5.8.2.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8.3. UAE
    • 5.8.3.1. Key Country Dynamics
    • 5.8.3.2. Regulatory Framework/ Reimbursement Structure
    • 5.8.3.3. Competitive Scenario
    • 5.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8.4. Israel
    • 5.8.4.1. Key Country Dynamics
    • 5.8.4.2. Regulatory Framework/ Reimbursement Structure
    • 5.8.4.3. Competitive Scenario
    • 5.8.4.4. Israel Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8.5. Kuwait
    • 5.8.5.1. Key Country Dynamics
    • 5.8.5.2. Regulatory Framework/ Reimbursement Structure
    • 5.8.5.3. Competitive Scenario
    • 5.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
• 6.3. Vendor Landscape
  • 6.3.1. Key Company Heat Map Analysis, 2024
• 6.4. Company Profiles
  • 6.4.1. Lineage, Inc.
    • 6.4.1.1. Company Overview
    • 6.4.1.2. Financial Performance
    • 6.4.1.3. Product Benchmarking
    • 6.4.1.4. Strategic Initiatives
  • 6.4.2. AmerisourceBergen Corporation
    • 6.4.2.1. Company Overview
    • 6.4.2.2. Financial Performance
    • 6.4.2.3. Product Benchmarking
    • 6.4.2.4. Strategic Initiatives
  • 6.4.3. DHL
    • 6.4.3.1. Company Overview
    • 6.4.3.2. Financial Performance
    • 6.4.3.3. Product Benchmarking
    • 6.4.3.4. Strategic Initiatives
  • 6.4.4. DB SCHENKER
    • 6.4.4.1. Company Overview
    • 6.4.4.2. Financial Performance
    • 6.4.4.3. Product Benchmarking
    • 6.4.4.4. Strategic Initiatives
  • 6.4.5. CARDINAL LOGISTICS
    • 6.4.5.1. Company Overview
    • 6.4.5.2. Financial Performance
    • 6.4.5.3. Product Benchmarking
    • 6.4.5.4. Strategic Initiatives
  • 6.4.6. MCKESSON CORPORATION
    • 6.4.6.1. Company Overview
    • 6.4.6.2. Financial Performance
    • 6.4.6.3. Product Benchmarking
    • 6.4.6.4. Strategic Initiatives
  • 6.4.7. Thermo Fisher Scientific Inc.
    • 6.4.7.1. Company Overview
    • 6.4.7.2. Financial Performance
    • 6.4.7.3. Product Benchmarking
    • 6.4.7.4. Strategic Initiatives
  • 6.4.8. PHCbi (PANASONIC HEALTHCARE CO., LTD)
    • 6.4.8.1. Company Overview
    • 6.4.8.2. Financial Performance
    • 6.4.8.3. Product Benchmarking
    • 6.4.8.4. Strategic Initiatives
  • 6.4.9. American Biotech Supply
    • 6.4.9.1. Company Overview
    • 6.4.9.2. Financial Performance
    • 6.4.9.3. Product Benchmarking
    • 6.4.9.4. Strategic Initiatives
  • 6.4.10. Arctiko
    • 6.4.10.1. Company Overview
    • 6.4.10.2. Financial Performance
    • 6.4.10.3. Product Benchmarking
    • 6.4.10.4. Strategic Initiatives
  • 6.4.11. NIPRO
    • 6.4.11.1. Company Overview
    • 6.4.11.2. Financial Performance
    • 6.4.11.3. Product Benchmarking
    • 6.4.11.4. Strategic Initiatives

관련자료